Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
FDA Approval Summary: Nogapendekin Alfa Inbakicept-pmln with BCG for BCG-Unresponsive Carcinoma In Situ.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 08, 2025
The comeback of orchiectomy in advanced prostate cancer- is that feasible?
Journal: Urologic oncology
Published: April 08, 2025
False-Positive Circulating Tumor DNA Results Do Not Explain Lack of Efficacy for PARP Inhibitors in Patients With Castration-Resistant Prostate Cancer Harboring ATM and CHEK2 Mutations.
Journal: JCO precision oncology
Published: August 29, 2024
FDA Approval Summary: Belzutifan for Patients with Advanced Renal Cell Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 19, 2024
Efficacy of Poly(ADP-ribose) Polymerase Inhibitors by Individual Genes in Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer: A US Food and Drug Administration Pooled Analysis.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 14, 2024
US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 07, 2024
Pharmacokinetic Simulation Analysis of Less Frequent Nivolumab and Pembrolizumab Dosing: Pharmacoeconomic Rationale for Dose Deescalation.
Journal: Journal of clinical pharmacology
Published: April 05, 2021
Comparison of out-of-pocket costs and adherence between the two arms of the prospective, randomized abiraterone food effect trial.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: March 08, 2021
COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia.
Journal: Clinical pharmacology and therapeutics
Published: September 25, 2020
COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19.
Journal: medRxiv : the preprint server for health sciences
Published: August 04, 2020
Clinical Activity of Olaparib in Urothelial Bladder Cancer With DNA Damage Response Gene Mutations.
Journal: JCO precision oncology
Published: November 01, 2018
Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer.
Journal: Journal for immunotherapy of cancer
Published: December 21, 2017
Last Updated: 09/26/2026